chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Parotitis
Clinical narrative: Information has been received from a physician concerning a 11 year old (also reported as 10 year old) male who on 14-OCT-1999 and 31-OCT-2002 was vaccinated with the first and second dose of MMR II respectively (route, site, and lot number not reported). On 25-JAN-2010 the patient experienced mumps. The patient was diagnosed on 26-JAN-2010. The patient parotitis was on right side and had right side of neck swollen. On 26-JAN-2010, the first blood work was done which revealed serum IgM <1:10, serum IgG 9.11 and serum Amylase 69. The outcome for mumps was not reported. This is one of several reports from the same source. Additional information has been requested.
Age: 1.2
Sex: M
Vaccine: MMR
Symptoms: Blood amylase increased, Blood immunoglobulin G, Blood immunoglobulin M, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning a 34 month old (also reported as 17 year old) male who on 20-MAY-2008 was vaccinated with the first dose of MMR II (route, site, and lot number not reported). The patient had not received the second dose. On 11-JAN-2010, the patient experienced mumps. The patient was diagnosed on 14-JAN-2010. The patient parotitis was on left side. On 14-JAN-2010, the first blood work was done which revealed serum IgM <1:10, serum IgG 4.66 and serum amylase 841. The outcome for mumps was not reported. This is one of several reports from the same source. Additional information has been requested.
Age: 1.2
Sex: M
Vaccine: MMR
Symptoms: Vaccine breakthrough infection
Clinical narrative: Information has been received from a physician concerning a 34 month old (also reported as 17 year old) male who on 20-MAY-2008 was vaccinated with the first dose of MMR II (route, site, and lot number not reported). The patient had not received the second dose. On 11-JAN-2010, the patient experienced mumps. The patient was diagnosed on 14-JAN-2010. The patient parotitis was on left side. On 14-JAN-2010, the first blood work was done which revealed serum IgM <1:10, serum IgG 4.66 and serum amylase 841. The outcome for mumps was not reported. This is one of several reports from the same source. Additional information has been requested.
Age: 6.0
Sex: F
Vaccine: VARCEL
Symptoms: Herpes zoster, Injection site rash
Clinical narrative: Information has been received from a nurse concerning her 6 year old daughter who two years ago, in March 2008, was intramuscularly vaccinated with a dose of VARIVAX (Merck). The within two months after receiving the VARIVAX (Merck), in approximately May 2008, the patient developed a rash on her leg at the injection site that was diagnosed as shingles. No lab tests were performed. The patient sought medical attention by an office visit. The patient was treated with an antiviral medication. On an unspecified date, the patient had recovered. No further information is available.
Sex: F
Vaccine: VARCEL
Symptoms: Scar, Skin hyperpigmentation, Varicella
Clinical narrative: Information has been received from a physician concerning a female patient with unspecified medical history, drug reactions or allergies, who on an unspecified date was vaccinated with a first dose of VARIVAX (Merck) (route and lot # unknown). Concomitant medications included "other vaccines that are usually provided at the 12 month visit". The physician reported that on an unspecified date, after receiving the first dose of VARIVAX (Merck), the patient developed varicella primarily on the upper thighs and it left some scarring and hyperpigmentation. No lab diagnostic studies performed. The patient sought unspecified medical attention. The patient recovered "about a week after developing varicella. Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test negative
Clinical narrative: Information has been received from a nurse practitioner concerning a nurse who on an unspecified date, in December 2006, was vaccinated with the first dose of VARIVAX (Merck) (lot # not reported).  In July 2007, the patient was vaccinated with the second dose of VARIVAX (Merck) (lot # not reported).  In April 2009, a titer was drawn and it was negative.  The patient had no symptoms.  Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Antibody test negative, Varicella virus test negative
Clinical narrative: Information has been received from a registered nurse concerning a patient who in 1996 was vaccinated with a dose of VARIVAX (Merck) (Lot# not reported). It was reported that the patient's titers were negative. It was unknown when titers were drawn. The patient sought unspecified medical attention. At the time of the report, the outcome of the patient was unknown. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Diarrhoea, Injection site nodule, Lymphadenopathy
Clinical narrative: Information has been received from a physician concerning a 12 month old male who on 22-JAN-2010 was vaccinated subcutaneously with a 0.5 mL first dose of VARIVAX (Merck) (lot # 665009/1042Y). Secondary suspect vaccination given on unspecified dates included doses of VAQTA (MSD), RECOMBIVAX HB (MSD) and MMR II (MSD). On 06-FEB-2010 the patient experienced diarrhea, swollen glands in the groin area and developed a nodule at the injection site. No laboratories studies performed. The patient sought medical attention through an office call. The patient recovered on an unspecified date. Additional information is not expected.
Age: 70.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning a 70 year old male patient who on an unspecified date was vaccinated with a dose of VARIVAX (Merck). It was reported that "soon after receiving the vaccine" the patient developed chickenpox. The patient sought medical attention with an office visit. At the time of the report the outcome of the patient was not reported. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a medical assistant in a physician's office concerning a patient who on approximately 17-OCT-2009 was vaccinated with a dose of VARIVAX (Merck) (lot#, route and site of administration not reported). On approximately 20-OCT-2009 ("6 weeks ago") the patient developed a mild case of chickenpox within 3 days of vaccination. Unspecified medical attention was sought via office visit. On an unspecified date, the patient recovered. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Immediate post-injection reaction, Urticaria
Clinical narrative: Information has been received from a registered nurse concerning a 12 month old female patient who on 03-DEC-2009 was vaccinated with a dose of VARIVAX (Merck) (Lot # not reported). Concomitant therapy included MMR II. The nurse stated that on 03-DEC-2009 the patient received VARIVAX (Merck) and MMR II and immediately developed hives all over her body. She was given BENADRYL IM and was kept in the office for 2 hours before returning home. At the time or this report, the patient's outcome was unspecified. No further information is available.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning a patient who on an unspecified date was vaccinated with a dose of VARIVAX (Merck) (name and manufacturer of the vaccine unspecified).  Subsequently the patient experienced chickenpox.  The physician was not the patient's physician.  Unspecified medical attention was sought.  It was unknown if lab studies performed.  The outcome of the patient was not reported.  No further information is available.
Sex: U
Vaccine: VARCEL
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a pharmacist concerning a patient who was supposed to receive ZOSTAVAX (Merck), "last week", on approximately 03-DEC-2009 was accidently vaccinated with VARIVAX (Merck) (lot not reported). No adverse effect was reported. At the time of the report, the outcome of the patient was not reported. Additional information has been requested.
Age: 43.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash vesicular
Clinical narrative: Information has been received from a pharmacist concerning a 43 year old female patient who on an unspecified date in May 2009, was vaccinated with the first dose of VARIVAX (Merck) (lot#, route and site of administration not reported). On an unspecified date the patient developed "varicella-like rash" after vaccination. At the time of this report, the patient had recovered. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: VARCEL
Symptoms: Herpes zoster, Laboratory test abnormal
Clinical narrative: Information has been received from a physician concerning a approximately 48 months old male patient who on an unspecified date was vaccinated with a dose of VARIVAX (Merck) (dose, route and lot# unspecified). Subsequently, several months post vaccination the patient developed severe herpes zoster in the arm in which VARIVAX (Merck) was administered. The patient recovered from the initial episode but subsequently experienced a recurrence of the herpes zoster. The patient had an immunologic work-up and was found to be immunocompromised, specifically he was found to have adenosine deaminase deficiency (ADA deficiency), which was likely present but undiagnosed at the time of vaccination. It was unknown if the patient sought medical attention. At the time of the report, the outcome of the event was unknown. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Information has been received from a registered nurse concerning a patient who on 17-NOV-2009 was inadvertently vaccinated with a standard dose of VARIVAX (Merck) (lot#, route and site of administration not reported) instead of ZOSTAVAX (Merck) which was administered by another nurse. No apparent adverse event was reported. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Skin lesion, Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning a 12 month old male patient who on 28-MAY-2009 was vaccinated with a 0.5ml dose of VARIVAX (Merck) (lot# 663814/0265Y). There was no concomitant medication. On 08-SEP-2009 the patient presented with chicken pox. The patient had 14 lesions on his trunk, 6 on his right arm, 5 on his left arm, 12 on his right leg and 25 on his left leg. On 22-SEP-2009, the patient's mother called the office saying that the patient was presenting with what looked like chicken pox again. Subsequently, the patient recovered on an unspecified date. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Blood immunoglobulin G, Blood immunoglobulin G normal, Blood immunoglobulin M, Blood immunoglobulin M normal, Mumps
Clinical narrative: Information has been received from a physician concerning a 13 year old male patient who on 25-NOV-1997 and 31-May-2001 was vaccinated with the first and second dose of MMR II (HSA) respectively. On 29-DEC-2009 the patient experienced mumps. The date diagnosed was 31-DEC-2009. The patient had no fever and had vomit once. The parotitis was on the left side. Lab diagnostic test performed: on 31-DEC-2009 the IgM was <1:10 and IgG was 5.82. At the time of report the patient's status was unknown. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Parotitis, Vomiting
Clinical narrative: Information has been received from a physician concerning a 13 year old male patient who on 25-NOV-1997 and 31-May-2001 was vaccinated with the first and second dose of MMR II (HSA) respectively. On 29-DEC-2009 the patient experienced mumps. The date diagnosed was 31-DEC-2009. The patient had no fever and had vomit once. The parotitis was on the left side. Lab diagnostic test performed: on 31-DEC-2009 the IgM was <1:10 and IgG was 5.82. At the time of report the patient's status was unknown. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning a 13 year old male (also reported as "7 year old") who on 22-JUL-1997 was vaccinated with the first dose of MMR II. On 29-AUG-2000 was vaccinated with the second dose of MMR II. On 03-DEC-2009 the patient experienced mumps (also reported diagnosed as "L parotitis" on 06-DEC-2009). It was unspecified if the patient sought medical attention. At the time of the report, the outcome was unknown. No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Blood amylase increased, Blood immunoglobulin G, Blood immunoglobulin M, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning a 13 year old male who was vaccinated with the first and the second dose of MMR II (lot # not provided) on 18-NOV-1997 and 20-JUL-2000 respectively. On 18-JAN-2010 the patient experienced mumps and it was swelling. On 20-JAN-2010, the first blood work revealed IgM<1:10, IgG was 7.92 and serum amylase was 562. On 20-JAN-2010, the patient was diagnosed with mumps. Parotitis was on the right. It was unspecified if the patient sought medical attention. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Swelling
Clinical narrative: Information has been received from a physician concerning a 13 year old male who was vaccinated with the first and the second dose of MMR II (lot # not provided) on 18-NOV-1997 and 20-JUL-2000 respectively. On 18-JAN-2010 the patient experienced mumps and it was swelling. On 20-JAN-2010, the first blood work revealed IgM<1:10, IgG was 7.92 and serum amylase was 562. On 20-JAN-2010, the patient was diagnosed with mumps. Parotitis was on the right. It was unspecified if the patient sought medical attention. Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: MMR
Symptoms: Blood amylase increased, Blood immunoglobulin G, Blood immunoglobulin M, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning a 12 year old (reported as 11 year old) male who on 23-DEC-1999 and 17-OCT-2002 was vaccinated with the first and second dose of MMR II respectively.  On 18-JAN-2010 the patient experienced mumps.  On 20-JAN-2010, the patient was diagnosed with mumps.  The patient had right parotitis.  His right cheek was swollen.  There were no other symptoms.  On 20-JAN-2010 1st blood work was performed and the results showed IgM <1:10, IgG 8.23 and serum amylase 379.  The patient did not receive the 3rd dose of MMR II.  At the time of the report, the outcome was unknown.  No further information is available.
Age: 5.0
Sex: M
Vaccine: MMR
Symptoms: Swelling face
Clinical narrative: Information has been received from a physician concerning a 12 year old (reported as 11 year old) male who on 23-DEC-1999 and 17-OCT-2002 was vaccinated with the first and second dose of MMR II respectively.  On 18-JAN-2010 the patient experienced mumps.  On 20-JAN-2010, the patient was diagnosed with mumps.  The patient had right parotitis.  His right cheek was swollen.  There were no other symptoms.  On 20-JAN-2010 1st blood work was performed and the results showed IgM <1:10, IgG 8.23 and serum amylase 379.  The patient did not receive the 3rd dose of MMR II.  At the time of the report, the outcome was unknown.  No further information is available.
Age: 1.97
Sex: M
Vaccine: MMR
Symptoms: Blood amylase increased, Blood immunoglobulin G, Blood immunoglobulin M, Body temperature increased, Mumps
Clinical narrative: Information has been received from a physician concerning a 12 year old (reported as 10 year old) male who on 15-JUN-1999 was vaccinated with the first dose of MMR II (HSA) (lot # reported as 1537A). On 30-NOV-2009 the patient experienced mumps. On 01-DEC-2009, the patient's temperature was 103 F and he was diagnosed with mumps. He had bilateral parotitis. On 01-DEC-2009 1st blood work was performed and the results showed IgM <1:10, IgG 2.71 and serum amylase 422. At the time of the report, the outcome was unknown. No further information is available.
Age: 1.97
Sex: M
Vaccine: MMR
Symptoms: Parotitis
Clinical narrative: Information has been received from a physician concerning a 12 year old (reported as 10 year old) male who on 15-JUN-1999 was vaccinated with the first dose of MMR II (HSA) (lot # reported as 1537A). On 30-NOV-2009 the patient experienced mumps. On 01-DEC-2009, the patient's temperature was 103 F and he was diagnosed with mumps. He had bilateral parotitis. On 01-DEC-2009 1st blood work was performed and the results showed IgM <1:10, IgG 2.71 and serum amylase 422. At the time of the report, the outcome was unknown. No further information is available.
Age: 3.0
Sex: M
Vaccine: MMR
Symptoms: Blood amylase increased, Blood immunoglobulin G, Blood immunoglobulin M, Mumps, Productive cough
Clinical narrative: Information has been received from a physician concerning a 12 year old male who on 18-JAN-1999 and on 13-AUG-2001 was vaccinated with the first and second doses (HSA) of MMR II, respectively. On 03-JAN-2010 the patient experienced left mumps. On the same day the patient was diagnosed with mumps. The patient was afebrile, had cough productive for 2 weeks and had coryza green for 1 weeks. The first blood work was done on 03-JAN-2010 and the results indicated IgM0.38, IgG 4.99 and serum amylase 193. It was reported the patient had exposed to mumps and 2 kids in his family also had mumps. At the time of the report, the patient's outcome was unknown, this case was non-serious. Additional information has been requested.
Age: 3.0
Sex: M
Vaccine: MMR
Symptoms: Rhinitis, Vaccine breakthrough infection
Clinical narrative: Information has been received from a physician concerning a 12 year old male who on 18-JAN-1999 and on 13-AUG-2001 was vaccinated with the first and second doses (HSA) of MMR II, respectively. On 03-JAN-2010 the patient experienced left mumps. On the same day the patient was diagnosed with mumps. The patient was afebrile, had cough productive for 2 weeks and had coryza green for 1 weeks. The first blood work was done on 03-JAN-2010 and the results indicated IgM0.38, IgG 4.99 and serum amylase 193. It was reported the patient had exposed to mumps and 2 kids in his family also had mumps. At the time of the report, the patient's outcome was unknown, this case was non-serious. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Mumps
Clinical narrative: Information has been received from a physician concerning a 12 year old male who on 06-AUG-1998 and on 06-JUN-2001 was vaccinated with the first dose and second doses of MMR II, respectively. On 04-DEC-2009 the patient experienced left mumps. On 07-DEC-2009 the patient was diagnosed with mumps. At the time of the report, the patient's outcome was unknown, this case was non-serious. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Blood amylase increased, Blood immunoglobulin G, Blood immunoglobulin M, Facial pain, Mumps
Clinical narrative: Information has been received from a physician concerning a 12 year old male who on 08-JUL-1998 was vaccinated with the first dose of MMR II (route, site, dose and lot number not reported). On 28-JUN-2001, the patient was vaccinated with the second dose of MMR II (route, site, dose and lot number not reported). On 20-JAN-2010 the patient experienced facial pain, parotitis and was diagnosed with Mumps. The outcome for mumps was not reported. On 21-Jan-2010, lab test performed revealed: serum mumps immunoglobulin M antibody test 1:10, serum mumps immunoglublin G antibody test 6.34, and serum amylase test 227. No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Parotitis
Clinical narrative: Information has been received from a physician concerning a 12 year old male who on 08-JUL-1998 was vaccinated with the first dose of MMR II (route, site, dose and lot number not reported). On 28-JUN-2001, the patient was vaccinated with the second dose of MMR II (route, site, dose and lot number not reported). On 20-JAN-2010 the patient experienced facial pain, parotitis and was diagnosed with Mumps. The outcome for mumps was not reported. On 21-Jan-2010, lab test performed revealed: serum mumps immunoglobulin M antibody test 1:10, serum mumps immunoglublin G antibody test 6.34, and serum amylase test 227. No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Blood amylase normal, Blood immunoglobulin G, Blood immunoglobulin M, Body temperature normal, Mumps
Clinical narrative: Information has been received from a physician concerning an 11 year old male who on 16-JUL-1998 was vaccinated with a first dose of MMR II HSA. On 23-APR-2001, the patient was vaccinated with a second dose of MMR II HSA. On 30-OCT-2009, the patent experienced mumps. On 01-NOV-2009, the patient was diagnosed with mumps. The patient was afebrile and had left parotitis. On 01-NOV-2009, the patient's lab results were serum IgM less than 1:10 and serum IgG was 6.12. On 07-DEC-2009, the patient's lab results were serum IgM less than 1:10, serum IgG was 7.23 and serum amylase was 40. The outcome of the mumps was not reported. No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Parotitis
Clinical narrative: Information has been received from a physician concerning an 11 year old male who on 16-JUL-1998 was vaccinated with a first dose of MMR II HSA. On 23-APR-2001, the patient was vaccinated with a second dose of MMR II HSA. On 30-OCT-2009, the patent experienced mumps. On 01-NOV-2009, the patient was diagnosed with mumps. The patient was afebrile and had left parotitis. On 01-NOV-2009, the patient's lab results were serum IgM less than 1:10 and serum IgG was 6.12. On 07-DEC-2009, the patient's lab results were serum IgM less than 1:10, serum IgG was 7.23 and serum amylase was 40. The outcome of the mumps was not reported. No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Blood amylase increased, Blood immunoglobulin G, Blood immunoglobulin M, Body temperature normal, Mumps
Clinical narrative: Information has been received from a physician concerning a 12 year old male who on 23-JUN-1998 was vaccinated with a first dose of MMR II. On 27-FEB-2001, the patient was vaccinated with a second dose of MMR II (route, site and lots number were not reported). On 06-DEC-2009 the patient experienced the onset of mumps. On 08-DEC-2009 the patient was diagnosed and experienced parotitis. The patient was afebrile. The patient was exposed to other classmate with mumps. On 27-NOV-2009, lab tests revealed: IgM 0.64, IgG, 5.62, and serum amylase 347. On 06-DEC-2009 the patient was diagnosed with mumps. This is one of several reports from the same source. No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Parotitis
Clinical narrative: Information has been received from a physician concerning a 12 year old male who on 23-JUN-1998 was vaccinated with a first dose of MMR II. On 27-FEB-2001, the patient was vaccinated with a second dose of MMR II (route, site and lots number were not reported). On 06-DEC-2009 the patient experienced the onset of mumps. On 08-DEC-2009 the patient was diagnosed and experienced parotitis. The patient was afebrile. The patient was exposed to other classmate with mumps. On 27-NOV-2009, lab tests revealed: IgM 0.64, IgG, 5.62, and serum amylase 347. On 06-DEC-2009 the patient was diagnosed with mumps. This is one of several reports from the same source. No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Blood amylase normal, Blood immunoglobulin G, Blood immunoglobulin M, Body temperature normal, Mumps
Clinical narrative: Information has been received from a physician concerning a 12 year old male patient with previous exposure to mumps who on 06-FEB-1997 was vaccinated with the first dose of MMR II and on 07-AUG-1999 received the second dose of MMR II. On 03-JAN-2010 the patient experienced mumps; the date of diagnosis was 05-JAN-2010. The patient presented with left parotitis and was afebrile. On 05-JAN-2010, the following laboratory tests were performed; serum immunoglobulin M test, 1:10; serum immunoglobulin G test 8.81; serum amylase test 162. The patient's final outcome was not reported.  No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Parotitis
Clinical narrative: Information has been received from a physician concerning a 12 year old male patient with previous exposure to mumps who on 06-FEB-1997 was vaccinated with the first dose of MMR II and on 07-AUG-1999 received the second dose of MMR II. On 03-JAN-2010 the patient experienced mumps; the date of diagnosis was 05-JAN-2010. The patient presented with left parotitis and was afebrile. On 05-JAN-2010, the following laboratory tests were performed; serum immunoglobulin M test, 1:10; serum immunoglobulin G test 8.81; serum amylase test 162. The patient's final outcome was not reported.  No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Mumps, Pain in jaw
Clinical narrative: Information has been received from a physician concerning an 11 year old male who on 23-AUG-1999 was vaccinated with the first dose of MMR II and on 28-AUG-2002, was vaccinated with the second dose of MMR II (HSA). On 04-DEC-2009, the patient experienced mumps, and was diagnosed on the same date. The patient was afebrile and as other symptoms he presented pain lower jaw. The first blood work was not done. The outcome from mumps was not reported. This is one of several reports received from the same source. No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Blood amylase increased, Blood immunoglobulin G, Blood immunoglobulin M, Body temperature increased, Mumps
Clinical narrative: Information has been received from a physician concerning a 11 year old male (also reported as 9 year old at onset date) who on 26-AUG-1999 and on 14-AUG-2002 was vaccinated with a first dose and a second dose of MMR II (lot # not reported), respectively. On 25-DEC-2009 the patient experienced mumps (diagnosed date was reported as 28-DEC-2009). The patient had fever of 102 F and experienced left parotitis. On 28-DEC-2009,  a blood work test showed IgM <1:10, IgG 9.34 and serum amylase 313. At the time of the report the patient's outcome was unknown. No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Parotitis, Pyrexia
Clinical narrative: Information has been received from a physician concerning a 11 year old male (also reported as 9 year old at onset date) who on 26-AUG-1999 and on 14-AUG-2002 was vaccinated with a first dose and a second dose of MMR II (lot # not reported), respectively. On 25-DEC-2009 the patient experienced mumps (diagnosed date was reported as 28-DEC-2009). The patient had fever of 102 F and experienced left parotitis. On 28-DEC-2009,  a blood work test showed IgM <1:10, IgG 9.34 and serum amylase 313. At the time of the report the patient's outcome was unknown. No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Blood amylase increased, Blood immunoglobulin G, Blood immunoglobulin M, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning a 12 year old male (also reported as 10 year old at onset date) who on 01-FEB-1999 and on 14-JAN-2002 was vaccinated with a first dose and a second dose of MMR II (lot # not reported), respectively. On 20-JAN-2010 the patient experienced mumps (diagnosis date was reported as 21-JAN-2010). The patient experienced right parotitis and right facial swelling, no other symptoms. On 21-JAN-2010, a blood work test showed IgM <1:10, IgG 10.61 and serum amylase 412. It was unknown if the patient was exposed to others with mumps (sibling or classmate). At the time of the report the patient's outcome was unknown. No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Swelling face
Clinical narrative: Information has been received from a physician concerning a 12 year old male (also reported as 10 year old at onset date) who on 01-FEB-1999 and on 14-JAN-2002 was vaccinated with a first dose and a second dose of MMR II (lot # not reported), respectively. On 20-JAN-2010 the patient experienced mumps (diagnosis date was reported as 21-JAN-2010). The patient experienced right parotitis and right facial swelling, no other symptoms. On 21-JAN-2010, a blood work test showed IgM <1:10, IgG 10.61 and serum amylase 412. It was unknown if the patient was exposed to others with mumps (sibling or classmate). At the time of the report the patient's outcome was unknown. No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Abdominal pain upper, Blood amylase increased, Blood immunoglobulin G, Blood immunoglobulin M, Body temperature normal
Clinical narrative: Information has been received from a health care professional concerning a 12 year old male who on 24-NOV-1998 was vaccinated with the first dose of MMR II. On 25-OCT-2009, the patient received the second dose of MMR II. On 20-NOV-2009 the patient experienced mumps, stomach pain and nausea. The patient experienced mumps (date diagnosed was reported as 23-NOV-2009). On 23-NOV-2009, the patient's blood work showed: a IgM <1:10, IgG 7.16 and serum amylase 568. The patient was afebrile and had left parotitis. The outcome for mumps was not reported. No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Mumps, Nausea, Parotitis
Clinical narrative: Information has been received from a health care professional concerning a 12 year old male who on 24-NOV-1998 was vaccinated with the first dose of MMR II. On 25-OCT-2009, the patient received the second dose of MMR II. On 20-NOV-2009 the patient experienced mumps, stomach pain and nausea. The patient experienced mumps (date diagnosed was reported as 23-NOV-2009). On 23-NOV-2009, the patient's blood work showed: a IgM <1:10, IgG 7.16 and serum amylase 568. The patient was afebrile and had left parotitis. The outcome for mumps was not reported. No further information is available.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Herpes zoster, Varicella post vaccine, Viral test positive
Clinical narrative: Information has been received from a physician concerning a now 15 year old male who in approximately 1994 (The reporter was "assuming when he was 12 months" old) was vaccinated with VARIVAX (Merck). Concomitant therapy included ACCUTANE. In approximately 1995 ("a year later") the patient's mother (not medically confirmed) that the patient had a mild case of chicken pox, about 10-14 spots. On approximately 26-APR-2009 ("last week") the patient experienced herpes zoster on his buttocks and was seen at the office. Viral culture was taken and diagnosed of herpes zoster was confirmed. The patient had began VALTREX in light of this diagnosis. The patient's status was recovering. Additional information has been requested.
Age: 9.0
Sex: F
Vaccine: FLUX, VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning a 10 year old female who on 11-APR-2008 was vaccinated with a 0.5 mL first dose of VARIVAX (Merck). On the same date the patient received a dose of MMR II (MSD). Concomitant therapy included influenza virus vaccine (manufacturer unspecified) on 12-NOV-2008. On the same date the patient received a second dose of VARIVAX (Merck) (lot #  661988/1190X). On 04-MAY-2009 the patient was broke out with 8 or 9 lesions and diagnosed with breakthrough chicken pox. No laboratories studies performed. The patient sought unspecified medical attention. At the time of this report the patient had not recovered. The patient was lost to follow up. No further information is available.
Age: 5.0
Sex: F
Vaccine: VARCEL
Symptoms: Blister, Herpes zoster, Pain
Clinical narrative: Information has been received from a physician concerning a 14 year old female with no pertinent medical history and drugs allergies who in April 2000, was vaccinated with a dose of VARIVAX (Merck).  There was no concomitant medication.  On 04-MAY-2009 the patient developed zoster.  The patient has 12-15 blisters on left dermatome and was experiencing pain.  No laboratories studies performed.  The patient sought medical attention through an office visit.  At the time of this report the patient had not recovered.  Additional information has been requested.
Age: 1.01
Sex: F
Vaccine: IPV, MMR, VARCEL
Symptoms: Agitation, Blood iron decreased, Decreased eye contact, Insomnia, Lymphocyte morphology abnormal
Clinical narrative: Information has been received from a physician concerning a approximately 12 month  old female who on 01-APR-2009 was vaccinated with MMR. Concomitant therapy included VARIVAX (Merck) and poliovirus vaccine inactivated (unspecified) "IPV". The patient had been "agitated and has had lack of eye contact" since she was given MMR. The physician also stated the patient had not been sleeping at night. Lab diagnostics were performed which revealed "lymphocytosis and low iron". The patient's events persisted. The patient sought medical attention and visited to the physician. Additional information has been requested.
Age: 1.01
Sex: F
Vaccine: IPV, MMR, VARCEL
Symptoms: Lymphocytosis, Urine iron decreased
Clinical narrative: Information has been received from a physician concerning a approximately 12 month  old female who on 01-APR-2009 was vaccinated with MMR. Concomitant therapy included VARIVAX (Merck) and poliovirus vaccine inactivated (unspecified) "IPV". The patient had been "agitated and has had lack of eye contact" since she was given MMR. The physician also stated the patient had not been sleeping at night. Lab diagnostics were performed which revealed "lymphocytosis and low iron". The patient's events persisted. The patient sought medical attention and visited to the physician. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Drug exposure during pregnancy, Vaccination complication
Clinical narrative: Information has been received from a female consumer who on an unspecified date was vaccinated with a dose MMR II (Lot not reported) and later she discovered she was pregnant. Subsequently, the patient experienced "every reaction possible". She continued to have unspecified problems on 03-APR-2009, which are believed to be based on the rubella component. At the time of reporting (03-APR-2009) the outcome of the patient was unknown. No further information is available.
Age: 1.09
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Nasopharyngitis
Clinical narrative: Information has been received from a consumer concerning her 12 month old son with pectus excavatum and left kidney enlargement who on 05-SEP-2008 was vaccinated with a 0.5 mL second dose of MMR subcutaneously. Patient received the first dose of MMR II about 7 months apart of the second one. Both times MMR II was given concomitantly with hepatitis A virus vaccine (unspecified) and varicella virus vaccine live (unspecified). The patient had a cold after received the MMR II, and his cold worsened that evening. No laboratories studies performed. The patient sought unspecified medical attention. The patient had not recovered. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: MMR
Symptoms: Apraxia
Clinical narrative: Information has been received from a registered nurse concerning his 12 month old son who on approximately 15-FEB-2006 was vaccinated with a first dose of MMR II.  The patient received the second dose of MMR II, however the vaccine components were split out and separated them by 1 month intervals.  On approximately 08-MAR-2006, three weeks after receiving the dose of MMR II the patient was diagnosed with apraxia.  This resolved within a few months with therapy. So far he had been fine.  It was also reported that one of the patient's brothers received the components of the vaccine separate by a month, and he was fine.  This is one of two reports from the same source.  Additional information has been requested.
Age: 4.0
Sex: F
Vaccine: MMR
Symptoms: Blood immunoglobulin G, Blood immunoglobulin M, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning a 10 year old girl who on 26-SEP-2000 was vaccinated with the first dose of MMR. On 24-JUN-2003, the patient was vaccinated with the second dose of MMR. On 23-DEC-2009, the patient experienced mumps. It was diagnosed on 05-NOV-2009 that the patient had left parotitis. The patient was afebrile. The first blood work on 09-NOV-2009 revealed IgM < 1:10, and IgG 8.11. The second blood work on 24-NOV-2009 revealed IgM <1:10, and IgG 8.2. At the time of this report, the patient's outcome was not reported. Follow-up information was received from the physician indicating that on 01-DEC-2009 the 10 (also reported as 8) year old patient developed mumps. It was diagnosed on 03-DEC-2009 that the patient had bilateral parotitis. The patient had jaw pain. It was reported that the first blood test on 03-DEC-2009 revealed IgM <1:10 and IgG 6.49. This is one of several reports from the same source. No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Blood amylase increased, Blood immunoglobulin G, Blood immunoglobulin M, Body temperature increased, Mumps
Clinical narrative: Information has been received from a physician concerning a 8 year old male who on 04-FEB-2003 was vaccinated with the first dose of MMR II. On 22-MAR-2006, the patient was vaccinated with the second dose of MMR II. On 02-DEC-2009 the patient experienced mumps. It was diagnosed on 15-DEC-2009 that the patient had left parotitis. The patient experienced fever which was 101 degree F. On 15-DEC-2009, the first blood work revealed that IgM was less than 1:10, IgG was 7.04, and serum amylase was 73. At the time of this report, the patient's outcome was not reported. Follow-up information was received from the physician indicating that on 03-JAN-2010, the 11 (previously reported as 8) year old patient developed mumps. On 05-JAN-2010, it was diagnosed that the patient had right parotitis. On 05-JAN-2010, the first blood work revealed that IgM was less than 1:10, IgG was 8.13, and serum amylase was 545. No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Parotitis, Pyrexia
Clinical narrative: Information has been received from a physician concerning a 8 year old male who on 04-FEB-2003 was vaccinated with the first dose of MMR II. On 22-MAR-2006, the patient was vaccinated with the second dose of MMR II. On 02-DEC-2009 the patient experienced mumps. It was diagnosed on 15-DEC-2009 that the patient had left parotitis. The patient experienced fever which was 101 degree F. On 15-DEC-2009, the first blood work revealed that IgM was less than 1:10, IgG was 7.04, and serum amylase was 73. At the time of this report, the patient's outcome was not reported. Follow-up information was received from the physician indicating that on 03-JAN-2010, the 11 (previously reported as 8) year old patient developed mumps. On 05-JAN-2010, it was diagnosed that the patient had right parotitis. On 05-JAN-2010, the first blood work revealed that IgM was less than 1:10, IgG was 8.13, and serum amylase was 545. No further information is available.
Age: 5.0
Sex: F
Vaccine: MMR
Symptoms: Blood amylase, Blood immunoglobulin G, Blood immunoglobulin M, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning a 17 year old female who on 11-FEB-1994 was vaccinated with the first dose of MMR II (lot number not reported) (HSA) and on 02-APR-1997 was vaccinated with the second dose of MMR II (HSA) (lot numbers not reported). On 17-NOV-2009, lab data revealed that IgM negative, IgG 5.88 and serum amylase 97. On the same date, the patient was diagnosed with mumps. The patient was afebrile. The patient had left parotitis. The onset date of mumps was reported as 30-NOV-2009. At the time of the report, the patient's outcome was unknown. Follow-up information was received which reported that the patient on 10-NOV-2009 experienced onset of symptoms. On 11-NOV-2009, the patient was diagnosed with mumps. On 11-NOV-2009, laboratory data revealed that IgM negative, IgG 5.16 and serum amylase 61. The patient was afebrile and had parotitis. At the time of the report, the patient's status was unknown. No further information is available.
Age: 5.0
Sex: F
Vaccine: MMR
Symptoms: Blood amylase, Blood immunoglobulin G, Blood immunoglobulin M, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning a 10 year old female who on 13-FEB-2002 was vaccinated with the first dose of MMR II (HSA) (lot number not reported) and on 11-AUG-2004 was vaccinated with the second dose of MMR II (HSA) (lot number not reported). On 30-NOV-2009, the patient experienced mumps. The patient was afebrile. On 02-DEC-2009, lab data revealed that IgM <1:10, IgG 1.73 and serum amylase 50. On the same date, the patient was diagnosed. The patient had parotitis. Follow-up information was received which reported that the patient on 15-JAN-2010 developed mumps. On 17-JAN-2010, the patient was diagnosed. The patient had parotitis. No laboratory tests were conducted. At the time of the report, the patient's status was unknown. No further information is available.
Age: 5.0
Sex: F
Vaccine: MMR
Symptoms: Vaccine breakthrough infection
Clinical narrative: Information has been received from a physician concerning a 10 year old female who on 13-FEB-2002 was vaccinated with the first dose of MMR II (HSA) (lot number not reported) and on 11-AUG-2004 was vaccinated with the second dose of MMR II (HSA) (lot number not reported). On 30-NOV-2009, the patient experienced mumps. The patient was afebrile. On 02-DEC-2009, lab data revealed that IgM <1:10, IgG 1.73 and serum amylase 50. On the same date, the patient was diagnosed. The patient had parotitis. Follow-up information was received which reported that the patient on 15-JAN-2010 developed mumps. On 17-JAN-2010, the patient was diagnosed. The patient had parotitis. No laboratory tests were conducted. At the time of the report, the patient's status was unknown. No further information is available.
Age: 6.0
Sex: M
Vaccine: MMR
Symptoms: Blood immunoglobulin G, Blood immunoglobulin M, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning a 17 year old male who "at 15 months old" (in approximately April 1993) and 02-FEB-1998 was vaccinated with the first and second doses of MMR II (Lot# not reported). On 06-NOV-2009 the patient experienced onset of symptoms. On 11-DEC-2009, the patient was diagnosed with mumps. The patient was afegrile and had parotitis. On 11-DEC-2009, blood work was done and revealed that IgM was <1:10, IgG was 4.6 and serum amylase was 103. The patient's outcome was unknown. Follow-up information was received which reported that the patient on 17-NOV-2009 experienced onset of symptoms. On 19-NOV-2009, the patient was diagnosed with mumps. The patient was afebrile and had parotitis. On 19-NOV-2009, blood work was done and revealed that IgM was <1:10, IgG was 9.13 and serum amylase was 30. The patient's outcome was unknown. The AE onset date and blood work date and results have been updated. No further information is available.
Age: 2.0
Sex: M
Vaccine: MMR
Symptoms: Blood amylase, Blood immunoglobulin G, Blood immunoglobulin M, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning a 17 year old male patient who on 02-DEC-1993 was vaccinated with the first dose of MMR II. On 09-OCT-1994, the patient received the second dose of MMR II. On 17-NOV-2009 laboratory diagnostic tests were performed: IgG 7.63; and serum amylase test: 361. On 17-NOV-2009, the patient was diagnosed and was afebrile. It was reported that on 25-NOV-2009 the patient experienced mumps outbreak. The outcome of the patient was not reported. Follow up information has been received from the physician who reported that the 17 year old patient (also reported as 16 year old at onset date) experienced mumps on 14-NOV-2009 (previously reported as on 25-NOV-2009). The date diagnosed was reported as 16-NOV-2009 (previously reported as 17-NOV-2009). The patient was afebrile and experienced parotitis. On 16-NOV-2009, the blood work test showed IgM negative, IgG 5.46 and serum amylase 317. At the time of the report the patient's outcome was unknown. No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Blood amylase, Blood immunoglobulin G, Blood immunoglobulin M, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning a 16 year old  female who on 28-DEC-1995 was vaccinated with the first dose of MMR II (lot number not reported) and on 06-MAY-1999 was vaccinated with the second dose of MMR II (lot number not reported). The patient did not fever. On 26-DEC-2009 the patient experienced mumps. On 31-DEC-2009, blood work was performed without result reported. On the same date, the patient was diagnosed as parotitis. Follow-up information was received which reported that the patient on 22-NOV-2009 developed mumps. On 24-NOV-2009, the patient was was diagnosed and afebrile, and laboratory data revealed that IgM <1:10, IgG 5.73 and serum amylase 150. The patient had parotitis on both sides. At the time of the report, the patient's status was unknown. No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Pyrexia
Clinical narrative: Information has been received from a physician concerning a 16 year old  female who on 28-DEC-1995 was vaccinated with the first dose of MMR II (lot number not reported) and on 06-MAY-1999 was vaccinated with the second dose of MMR II (lot number not reported). The patient did not fever. On 26-DEC-2009 the patient experienced mumps. On 31-DEC-2009, blood work was performed without result reported. On the same date, the patient was diagnosed as parotitis. Follow-up information was received which reported that the patient on 22-NOV-2009 developed mumps. On 24-NOV-2009, the patient was was diagnosed and afebrile, and laboratory data revealed that IgM <1:10, IgG 5.73 and serum amylase 150. The patient had parotitis on both sides. At the time of the report, the patient's status was unknown. No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Blood amylase, Blood immunoglobulin G, Blood immunoglobulin M, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning a 17 year old male who on 23-DEC-1993 was vaccinated with the first dose of MMR II (HSA) (lot number not reported) and on 21-AUG-1996 was vaccinated with the second dose of MMR II (HAS) (lot number not reported). The patient had no fever. On 16-NOV-2009 the patient experienced mumps and on the same date the patient was diagnosed as parotitis. Follow-up information was received which reported that the patient on 22-NOV-2009 developed mumps. On 23-NOV-2009, the patient was diagnosed and was afebrile, and laboratory data revealed that IgM 0.35, IgG 4.43 and serum amylase 172. The patient had parotitis on both sides. At the time of the report, the patient's status was unknown. No further information is available.